Source link : https://newshealth.biz/health-news/efgartigimod-promising-for-rare-pediatric-disease/
Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare condition with few effective treatment options. Medscape Medical News Source link : https://www.medscape.com/viewarticle/efgartigimod-promising-rare-pediatric-disease-few-treatment-2025a1000u97?src=rss Author : Publish date : 2025-11-04 06:47:00 Copyright for syndicated content belongs to the linked Source.
The post Efgartigimod Promising for Rare Pediatric Disease first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-04 06:47:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8